Canadian biotech company Avivagen ready to enter US market

Canadian biotech company Avivagen ready to enter US market

Photo by Andrea Gantz

OxC-beta approval in the United States has opened business opportunities for the Canadian-based company

Canadian biotech and animal health company Avivagen has received more than $5 million in funding intended to increase its presence in the U.S. marketplace.